The Penicillins and Streptomycins dosage market in New Zealand experienced fluctuations from 2013 to 2023, peaking at $15.03 per capita in 2013 and declining to $11.59 in 2023. Over the last two years, there was a notable decrease in market value, with a 12.4% decline from 2021 to 2023. The compound annual growth rate (CAGR) for the past five years stands at -3.7%, indicating a downtrend in market value per capita.
Future trends to watch include:
- Technological advancements in antibiotics which may affect usage and prescription patterns.
- Public health policies influencing antibiotic stewardship and consumption.
- Potential shifts towards alternative treatments or new market entrants affecting penicillin and streptomycin sales.
